Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Debt to Equity (2021 - 2022)

Historic Debt to Equity for Mereo BioPharma (MREO) over the last 2 years, with Q4 2022 value amounting to $0.01.

  • Mereo BioPharma's Debt to Equity fell 9421.55% to $0.01 in Q4 2022 from the same period last year, while for Dec 2022 it was $0.01, marking a year-over-year decrease of 9421.55%. This contributed to the annual value of $0.16 for FY2021, which is N/A changed from last year.
  • As of Q4 2022, Mereo BioPharma's Debt to Equity stood at $0.01, which was down 9421.55% from $0.23 recorded in Q2 2022.
  • Mereo BioPharma's 5-year Debt to Equity high stood at $0.23 for Q2 2022, and its period low was $0.01 during Q4 2022.